Pharmacy chain CVS has stepped up its drive into the wider healthcare market with an agreement to buy at-home care and technology provider Signify Health for around $8 billion – reportedly
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh